Erratum to: GLP-1: Benefits beyond pancreas

G. Muscogiuri; A. Cignarelli; F. Giorgino; F. Prodam; D. Santi; G. Tirabassi; G. Balercia; R. Modica; A. Faggiano; A. Colao

doi:10.1007/s40618-014-0188-0

Erratum to: GLP-1: Benefits beyond pancreas

G. Muscogiuri
, A. Cignarelli
, F. Giorgino
, F. Prodam
, D. Santi
, G. Tirabassi
, G. Balercia
, R. Modica
, A. Faggiano
, A. Colao

Department of Health Sciences

Research output: Contribution to journal › Comment/debate

Abstract

Glucagon-like peptide 1 (GLP-1) is an intestinal hormone secreted after the ingestion of various nutrients. The main role of GLP-1 is to stimulate insulin secretion in a glucose-dependent manner. However, the expression of GLP-1 receptor was found to be expressed in a variety of tissues beyond pancreas such as lung, stomach, intestine, kidney, heart and brain. Beyond pancreas, a beneficial effect of GLP-1 on body weight reduction has been shown, suggesting its role for the treatment of obesity. In addition, GLP-1 has been demonstrated to reduce cardiovascular risk factors and to have a direct cardioprotective effect, fostering heart recovery after ischemic injury. Further, data from both experimental animal models and human studies have shown beneficial effect of GLP-1 on bone metabolism, either directly or indirectly on bone cells.

Original language	English
Pages (from-to)	115
Number of pages	1
Journal	Journal of Endocrinological Investigation
Volume	38
Issue number	1
DOIs	https://doi.org/10.1007/s40618-014-0188-0
Publication status	Published - 1 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s40618-014-0188-0

Cite this

@article{2a19d016de734b4e93bad16ea80547a5,

title = "Erratum to: GLP-1: Benefits beyond pancreas",

abstract = "Glucagon-like peptide 1 (GLP-1) is an intestinal hormone secreted after the ingestion of various nutrients. The main role of GLP-1 is to stimulate insulin secretion in a glucose-dependent manner. However, the expression of GLP-1 receptor was found to be expressed in a variety of tissues beyond pancreas such as lung, stomach, intestine, kidney, heart and brain. Beyond pancreas, a beneficial effect of GLP-1 on body weight reduction has been shown, suggesting its role for the treatment of obesity. In addition, GLP-1 has been demonstrated to reduce cardiovascular risk factors and to have a direct cardioprotective effect, fostering heart recovery after ischemic injury. Further, data from both experimental animal models and human studies have shown beneficial effect of GLP-1 on bone metabolism, either directly or indirectly on bone cells.",

author = "G. Muscogiuri and A. Cignarelli and F. Giorgino and F. Prodam and D. Santi and G. Tirabassi and G. Balercia and R. Modica and A. Faggiano and A. Colao",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/s40618-014-0188-0",

language = "English",

volume = "38",

pages = "115",

journal = "Journal of Endocrinological Investigation",

issn = "0391-4097",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Erratum to

T2 - GLP-1: Benefits beyond pancreas

AU - Muscogiuri, G.

AU - Cignarelli, A.

AU - Giorgino, F.

AU - Prodam, F.

AU - Santi, D.

AU - Tirabassi, G.

AU - Balercia, G.

AU - Modica, R.

AU - Faggiano, A.

AU - Colao, A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Glucagon-like peptide 1 (GLP-1) is an intestinal hormone secreted after the ingestion of various nutrients. The main role of GLP-1 is to stimulate insulin secretion in a glucose-dependent manner. However, the expression of GLP-1 receptor was found to be expressed in a variety of tissues beyond pancreas such as lung, stomach, intestine, kidney, heart and brain. Beyond pancreas, a beneficial effect of GLP-1 on body weight reduction has been shown, suggesting its role for the treatment of obesity. In addition, GLP-1 has been demonstrated to reduce cardiovascular risk factors and to have a direct cardioprotective effect, fostering heart recovery after ischemic injury. Further, data from both experimental animal models and human studies have shown beneficial effect of GLP-1 on bone metabolism, either directly or indirectly on bone cells.

AB - Glucagon-like peptide 1 (GLP-1) is an intestinal hormone secreted after the ingestion of various nutrients. The main role of GLP-1 is to stimulate insulin secretion in a glucose-dependent manner. However, the expression of GLP-1 receptor was found to be expressed in a variety of tissues beyond pancreas such as lung, stomach, intestine, kidney, heart and brain. Beyond pancreas, a beneficial effect of GLP-1 on body weight reduction has been shown, suggesting its role for the treatment of obesity. In addition, GLP-1 has been demonstrated to reduce cardiovascular risk factors and to have a direct cardioprotective effect, fostering heart recovery after ischemic injury. Further, data from both experimental animal models and human studies have shown beneficial effect of GLP-1 on bone metabolism, either directly or indirectly on bone cells.

UR - https://www.scopus.com/pages/publications/84923918468

U2 - 10.1007/s40618-014-0188-0

DO - 10.1007/s40618-014-0188-0

M3 - Comment/debate

SN - 0391-4097

VL - 38

SP - 115

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

IS - 1

ER -

Erratum to: GLP-1: Benefits beyond pancreas

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this